BML-111, the lipoxin A4 agonist, modulates VEGF or CoCl2-induced migration, angiogenesis and permeability in tumor-derived endothelial cells
Lan Lin, Qingyu Wang, Fen Xu, Xuliang Luo, Jing Xu, Liping Yan, Qing Li, Hua Hao
Topics & Concepts
AngiogenesisCancer researchVascular permeabilityTumor microenvironmentChemistryNeovascularizationCell biologyBiologyEndocrinologyTumor cellsAngiogenesis and VEGF in CancerCancer, Lipids, and MetabolismCancer, Hypoxia, and Metabolism